Effects of Combined Music Therapy and Occupational Therapy on Motor and Physiological Parameters in Children With Neurological Impairments: A Non-Randomized Controlled Trial

Effects of Combined Music Therapy and Occupational Therapy on Motor and Physiological Parameters in Children With Neurological Impairments: A Non-Randomized Controlled Trial

This study aims to explore the effects of an occupational therapy program combined with music therapy elements on children 5-12 years old with neurological disorders including those with neurogenic scoliosis. Occupational therapy programs typically focus on improving motor and cognitive functions to enhance the child's overall participation and daily functioning. Music has been shown to positively affect brain areas involved in emotions, memory, and language, and may reduce stress and increase feelings of happiness.

The study will measure changes in biological markers such as blood pressure, oxygen saturation, heart rate, and respiratory rate, as well as improvements in functionality for upper limbs but also balance and walking ability after the therapy program. These markers can provide valuable information about the physical health and quality of life of the children, which is currently lacking for the Greek population.

By investigating these biological indicators along with functional outcomes, this research hopes to offer new insights into the benefits of combining music therapy with occupational therapy. This may encourage better engagement from families and support rehabilitation specialists in demonstrating the value of their interventions even before functional improvements become noticeable

Inclusion Criteria:

Diagnosis of a neurological condition with established neurological signs (e.g., motor or cognitive impairments)

• Cerebral Palsy (GMFCS levels I-II),
• Brain infections (e.g., encephalitis),
• Brain neoplasms
• Ability to follow simple instructions and participate in an occupational therapy program,
• Medical clearance to participate in physical activity

Exclusion Criteria:

• Degenerative neurological diseases,
• Metabolic disorders affecting the nervous system,
• Neuromuscular disorders, including muscular dystrophy and congenital myopathies,
• Peripheral nervous system damage,
• Current use of corticosteroids,
• Botulinum toxin injection within 30 days prior to the intervention program,
• Hearing loss or diagnosed deafness